Table 6.

Current registration and recommended use of Maraviroc in African countries

African countries	Year of registration (Registering authority)	Recommendation in treatment guidelines/remarks	URL links
South Africa	2013 (Medicines Control Council)	Not included in the national treatment guidelines, but the Southern African HIV Clinicians Society recommends its use as salvage therapy	https://www.sahpra.org.za/documents/149a634812.71_Notification_of_Registration_Mar13_v1.pdf Accessed 20 Jan 2020 https://sahivsoc.org/Files/2014%20Adult%20ART%20Guideline%20(Dec%202014).pdf Accessed 14 Jan 2020
Tanzania	Information on registration or of the registering authority is not available	Recommended in the national treatment guidelines as a component in third line treatment by the Ministry of Health, Community Development, Gender, Elderly, and Children	https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=2ahUKEwj3rtrNsIXnAhV2QkEAHSBnDuoQFjAAegQIARAC&url=http%3A%2F%2Fwww.nacp.go.tz%2Fsite%2Fdownload%2FNATIONAL_DECEMBER_2017.pdf&usg=AOvVaw0XAyt4IPPIA8OE_-qSR9no Accessed 14 Jan 2020
Uganda	2008 (National drug register of Uganda Human Medicines)	Currently not recommended in the national treatment guidelines	https://www.nda.or.ug/Linked%20publications/NATIONAL%20DRUG%20REGISTER%20HUMAN%20JANUARY%202020.pdf Accessed 14 Jan 2020
Zambia	Information on registration or the registering authority is not available	Recommended in the national treatment guidelines as a component in third line treatment by the Ministry of Health	http://www.hivst.org/files1/Final-Zambia-Consolidated-Guidelines_2018-Print.pdf Accessed 14 Jan 2020

In these four countries, a specialist committee recommends the use of maraviroc based on HIV drug resistance genotyping data for virologic failure, and HIV tropism test